Related Experiment Video
Updated: Apr 30, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
661
Anatomical thoracoscopic segmentectomy for lung cancer
Yoichi Ohtaki1, Kimihiro Shimizu
1Department of Thoracic and Visceral Organ Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
General Thoracic and Cardiovascular Surgery
|May 6, 2014
Summary
Thoracoscopic segmentectomy offers a less invasive approach for lung cancer, preserving lung function. Further research is needed to confirm long-term oncological outcomes, but it shows promise for patient recovery.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Minimally invasive surgery is advancing for lung cancer treatment.
- Segmentectomy preserves lung parenchyma, potentially reducing complications compared to lobectomy.
- Thoracoscopic segmentectomy shows promise for safety and feasibility.
Purpose of the Study:
- To review surgical and oncological outcomes of thoracoscopic segmentectomy for lung cancer.
- To evaluate the utility of 3D-CT angiography and bronchography (3D-CTAB) in preoperative planning.
- To describe surgical techniques for thoracoscopic segmentectomy.
Main Methods:
- Review of retrospective studies on thoracoscopic segmentectomy.
- Evaluation of preoperative simulation using 3D-CT and 3D-CTAB.
- Description of surgical procedures and techniques.
Main Results:
- Thoracoscopic segmentectomy appears safe and feasible with lower complication rates than open thoracotomy.
- Evidence on long-term oncological outcomes is limited.
- 3D-CTAB aids in precise identification of vascular and bronchial structures.
Conclusions:
- Thoracoscopic segmentectomy is a viable option for specific lung cancers, offering potential benefits in recovery.
- Further prospective studies are crucial to establish long-term oncological efficacy.
- Advanced imaging like 3D-CTAB enhances surgical precision and safety.
